High Tide Acquires 51% of Remexian Pharma GmbH

September 2, 2025

High Tide Inc. completed its acquisition of a 51% interest in Remexian Pharma GmbH for an estimated €26.4 million, with the final purchase price to be finalized within 30 days after the closing balance sheet is available. The deal also includes options for High Tide to acquire the remaining 49% (call option) and for the sellers to put their remaining stake to High Tide (put option).

Buyers
High Tide Inc.
Targets
Remexian Pharma GmbH
Sellers
Remexian's owners
Location
Germany
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.